HDFC Life Q4 FY26: APE ₹5,250cr, EV up 12%

Key takeaway for investors watching ₹740

HDFC Life Insurance (HDFCLIFE) heads into the Q4 FY26 results season with the stock trading around ₹740 in early April 2026. The price is well below the 52-week high of ₹972 and above the 52-week low of ₹620, and the stock has delivered a 1-year return of -18% as cited in the note.

Against this backdrop, Q4 and FY26 operating metrics matter because they shape expectations on growth, margins, and embedded value. The latest update points to steady premium-equivalent growth but a softer value-of-new-business margin in Q4. Broker views remain broadly constructive, but near-term debate is centered on how quickly margins normalise after the GST transition and product mix shifts.

Q4 FY26 APE: growth driven by group business

In 4QFY26, HDFC Life reported Annualised Premium Equivalent (APE) of ₹5,250 crore, described as in line. This was up 1% year-on-year.

The mix within APE shows different trajectories. Individual APE was flat year-on-year, while group APE rose 10% year-on-year. This split is relevant because product and channel mix can influence value creation and margins, especially when growth is more pronounced in group business.

The update also flags that the company is entering FY27 with a largely completed GST transition, a supportive yield curve, an improving agency channel, and a strengthening protection portfolio.

FY26 APE: ₹16,640 crore, up 8% YoY

For the full year FY26, APE grew 8% year-on-year to about ₹16,640 crore. This places FY26 growth ahead of the near-flat Q4 trend, implying quarterly growth rates were uneven through the year.

The company’s stated aspiration is to outpace industry growth in APE. It also expects VNB growth to be better than APE growth, which signals a focus on improving product mix and economics rather than only chasing volumes.

Q4 FY26 VNB: margin slips to 24%

Value of New Business (VNB) declined 8% year-on-year in 4QFY26 to ₹1,260 crore, also described as in line. The VNB margin for the quarter came in at 24%, down from 26.5% in 4QFY25.

The note cites an estimated margin of 24.8% for the quarter, highlighting that the reported 24% was modestly below that reference point. For investors, this matters because VNB margin is a key driver of profitability and embedded value compounding in life insurance.

FY26 VNB: ₹4,030 crore, margin at 24.2%

For FY26, VNB grew 2% year-on-year to ₹4,030 crore. The FY26 VNB margin stood at 24.2%, compared with 25.6% in FY25.

This combination of modest VNB growth and lower full-year margin helps explain why some brokerages are trimming forward margin assumptions. The update explicitly mentions a cut to VNB margin estimates by 150 basis points for FY27 and 100 basis points for FY28, while keeping premium estimates unchanged.

Embedded value: ₹62,140 crore with 15% operating RoEV

HDFC Life’s embedded value (EV) at FY26-end was ₹62,140 crore, up 12% year-on-year. Operating RoEV for the year was 15%.

EV and RoEV are closely watched because they bring together expected profitability, growth, and capital strength into a consolidated measure. A 12% EV rise and 15% operating RoEV provide context for how the company is compounding value even as near-term VNB margins fluctuate.

Stock levels and why the Q4 print is closely watched

The stock was cited at a current market price of ₹740 as of early April 2026. The same note highlights the 52-week high of ₹972 and 52-week low of ₹620.

With a -18% 1-year return referenced, Q4 FY26 results are positioned as an important checkpoint for investors assessing whether to hold, add, or reduce exposure. The market will likely focus on the pace of individual business growth, the contribution of group APE, and whether VNB margin stabilises.

What brokerages are saying: ratings and targets

Multiple brokerages listed in the note have positive ratings heading into the results, with targets clustering well above the ₹740 level.

Separately, another excerpt states that Motilal Oswal maintained a Buy rating with a target of ₹930, and a report mentioned Citi also maintained a Buy rating with a target of ₹1,020.

Estimates in focus: PAT and revenue ranges cited

The note also references analyst projections of PAT at ₹450–520 crore and revenue of ₹28,000–31,000 crore, described as continued sequential growth from Q3 FY26 levels.

While these are projections rather than reported numbers, they frame expectations into the Q4 result. Any material deviation, particularly on margins or value metrics, can influence how targets evolve.

Market impact: the margin debate versus growth levers

On the growth side, FY26 APE increased 8% year-on-year to ₹16,640 crore, and EV rose 12% year-on-year to ₹62,140 crore. The company also enters FY27 with a supportive yield curve and improving agency channel, along with a strengthening protection portfolio.

On the margin side, Q4 VNB margin fell to 24% from 26.5% a year ago, and FY26 VNB margin declined to 24.2% from 25.6% in FY25. Reflecting this, one brokerage note kept premium estimates but reduced VNB margin estimates by 150 basis points for FY27 and 100 basis points for FY28, with operating RoEV around 15%.

The same note reiterated a BUY rating with a revised target price of ₹760, based on 2x FY28E EV. That valuation reference indicates the sensitivity of target prices to EV growth and margin assumptions.

Conclusion: FY27 setup depends on margin stabilisation

HDFC Life’s FY26 showed APE growth to ₹16,640 crore and EV growth to ₹62,140 crore, while Q4 saw APE at ₹5,250 crore and VNB at ₹1,260 crore with a 24% margin. With the stock near ₹740 and broker targets largely higher, the next key data points are the company’s commentary on the post-GST transition environment, agency momentum, and protection mix.

The insurer has said it aims to outpace industry APE growth and expects VNB growth to exceed APE growth. Investors will look for confirmation of that trajectory in FY27 guidance and subsequent quarterly disclosures.